Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
PrEP Prescriptions on Dramatic Upswing in New York State

In less than a year, the number of New York State residents receiving Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) prescriptions through Medicaid has nearly tripled. According to Dan O’Connell, director of the AIDS Institute at the New York State Department of Health, from July 2013 through June 2014, 305 HIV-negative New Yorkers were taking Truvada to prevent infection with the virus. By the close of February 2015, that figure had jumped 272 percent to 832 people.

Published
14 May 2015
From
POZ
Abstinence-only curriculum is not sex education, judge rules

California’s sex-education law prohibits school districts from indoctrinating students on the need to remain celibate before marriage or teaching them that abstinence is the only safe way to prevent pregnancy and sexually transmitted diseases, a judge has ruled.

Published
14 May 2015
From
SFGate
Truvada PrEP causes only mild loss of bone mineral density

Treatment with tenofovir/emtricitabine (Truvada) as pre-exposure prophylaxis (PrEP) is associated with small but significant decreases in bone mineral density (BMD), investigators from the landmark iPrEx study report in the

Published
14 May 2015
By
Michael Carter
Lottery Ticket Approach Leads to Drastic Reduction in HIV Prevalence

Researchers funded by the World Bank arrived at a wildly unorthodox and unexpectedly effective strategy for preventing HIV in the African nation of Lesotho: A lottery program that offered participants an opportunity to win cash on the condition that they tested negative for sexually transmitted infections. “As risky sexual behavior, which is responsible for the vast majority of new HIV infections, also involves a risky gamble, lottery programs may better target those at higher risk of getting infected by HIV,” the authors wrote in a World Bank working paper published in March.

Published
13 May 2015
From
Foreign Policy
How PrEP Is Being Blocked By Bureaucracy

Bureaucracy and deliberate attempts to block prevention techniques are slowing down Los Angeles’s ability to disseminate PrEP.

Published
12 May 2015
From
The Advocate
First French Cities Apply for Drug Consumption Rooms Under New Law

Strasbourg, Bordeaux and Paris have submitted applications to implement supervised injection sites (SISs) for drug users, becoming the first cities to do so under a groundbreaking law introduced last month.

Published
12 May 2015
From
Talking Drugs
HIV immunity: rare gene differences offer hope for treatment

Seven years after the ‘Berlin patient’ was cured of HIV, scientists are looking to natural immunity through genetic variation to create vaccine and gene therapies

Published
12 May 2015
From
The Guardian
Moving Video Shows HIV-Positive Men Asking for PrEP Approval in Australia

The Victorian AIDS Council (VAC) has released a video online featuring Australian community leaders who are living with HIV delivering a powerful message: They would still be HIV negative today if PrEP had been available to them prior to their seroconversion. The video is part of the campaign #approvePrEPdownunder, which is hoping to pressure the Australian government to approve PrEP for use in Australia.

Published
11 May 2015
From
TheBody.com
Five Sexy Gay Men On HIV PrEP Explain Why They Are Taking The Pill

So much of the conversation about pre-exposure prophylaxis (PrEP) has been reduced to labeling the people taking PrEP (“Truvada whore,” and more) instead of listening to them. Queerty wanted to get past those labels, so we spoke to five gay men on PrEP about why they chose to take a pill to prevent HIV infection — and their thoughts on the debate about it and the changes in their sexual lives that it inspired.

Published
11 May 2015
From
Queerty
Does Llama Blood Hold the Key to an HIV Vaccine?

Previous research suggested that llamas given an experimental HIV vaccine produce virus-fighting antibodies that are smaller than those produced by humans. As a result, these smaller antibodies do a better job of latching onto the receptors in human cells where part of the virus lives. An HIV vaccine should target these receptors.

Published
11 May 2015
From
Healthline

Filter by country